Retina Implant AG Presents New Insights into Artificial Vision for the Blind at the Association for Research in Vision & Ophthalmology Annual Meeting

REUTLINGEN, Germany--(BUSINESS WIRE)--Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of findings from their first clinical trial in which blind patients were able to view and focus on objects as their eye and head naturally moved as opposed to needing to constantly move their head to scan a scene, which is the case for other implants in which a camera is mounted to the patient’s head. The presentation delivered by lead author, Professor Eberhart Zrenner, M.D., director and chairman of the Institute for Ophthalmic Research at the Center for Ophthalmology of the University of Tuebingen, Germany, is one of twelve Retina Implant-related presentations being presented at the 2010 Association for Research in Vision and Ophthalmology (ARVO) annual meeting convening May 2-6 in Fort Lauderdale, Fla.